The Food and Drug Administration will announce on Monday that it has sent over 2,200 letters pressing drug manufacturers, ...
An FDA review of records in the U.S. clinical trials database shows that results have not been reported for 30% of clinical ...
Clinical Trials Arena on MSN
FDA cracks down on sponsor and researchers’ failure to publish trial data
The FDA has sent letters to more than 2,200 sponsors and investigators regarding more than 3,000 studies.
FDA officials said an internal analysis found results were not submitted for nearly 30% of studies “highly likely” to fall ...
An op-ed published by MedPage Today in 2023 that called for more aggressive enforcement of the data reporting law said the ...
Faculty in this hub lead the design, coordination, and analysis of clinical trials for cancer treatment, survivorship, vaccine efficacy, infectious disease prevention and treatment, and cancer ...
Thermo Fisher Scientific, the world leader in serving science, today announced a strategic data collaboration with HealthVerity, a leading real-world data (RWD) marketplace, to enhance data-driven ...
U.S. Food and Drug Administration (FDA) guidance states that payment for participation in clinical trials must be just, fair, and receive approval from an institutional review board (IRB). According ...
1. FDA Reminds More Than 2,200 Sponsors and Researchers to Disclose Trial Results. News release. FDA. April 13, 2026.
The adoption of AI in clinical trials holds the potential to revolutionize how therapies are discovered, but the pace of that ...
In this segment, Dr. Morrison discusses the clinical evidence supporting subcutaneous immunotherapy and explains the concept ...
Trial Designed to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SEP-479 in Healthy Volunteers Data Anticipated in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results